D081KC00001: Phase I/II Study of MED14736 (Anti-PD-L1 Antibody) in Combination with Olaparib (PARP inhibitor) in Patients with Advanced Solid Tumors (MEDIOLA)

February 17, 2019
https://clinicaltrials.gov/ct2/results?id=NCT02734004
Cancer - Esophageal, Cancer - Breast, Cancer - Ovarian, Solid Tumors
Principal Investigator: Ding Wang, MD
Cancer, Breast Cancer, Ovarian Cancer, Solid tumors, Advanced Solid tumors, Gastric Cancer, Phase 1, Phase 2, Phase I, Phase II, MEDIOLA, MEDI4736, Esophageal cancer, Esophageal
Open